Anaerobic Exercise and Mental Acuity
Status
Conditions
Treatments
Details and patient eligibility
About
This is a randomized controlled trial to examine the effect of anaerobic activity (e.g., weight training) on gut microbiome metabolism and neurological health in healthy sedentary men.
Full description
The human gut microbiome, which houses over 2,000 distinct bacterial species, has recently been characterized as a highly influential force on the health and longevity of its host. By way of several distinct pathways comprising the "microbiome-gut-brain axis", this diverse population is known to communicate with the human brain in a bidirectional manner and is implicated in the pathophysiology of several metabolic and psychological disease states. The ability to support a healthy, diverse microbiome through modifiable behavioral interventions - such as diet and exercise - is a topic of growing interest. Most of the evidence pertaining to the relationship between physical activity and the gut-brain axis at this time, however, investigates the influence of aerobic exercise providing limited insight to how other modalities of physical activity may differ. Specifically, this study will examine the impact of an 8-week weight training protocol on gut microbiome metabolism and neurological health in healthy sedentary men. Participants will be randomly assigned to the intervention group or the waitlist control group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- free of any existing medical diagnoses
- willing and able to participate in moderate to vigorous exercise as determined by the ACSM Health/Fitness Facility Preparticipation Screening Questionnaire
- sedentary (defined as a score <14 on the Godin-Shepard Leisure Time Physical Activity Questionnaire (GSLTQ))
- equipped with access to a complete gym
Exclusion criteria
- antibiotic use within the past six months
- prebiotic, probiotic, or high-dose antioxidant supplementation within the past 6 months
- smoker (cigarettes and/or marijuana)
- regular laxative use
- blood pressure >129/80 at baseline
Trial design
Primary purpose
Allocation
Interventional model
Masking
23 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Carol S Johnston
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal